LEXICON PHARMACEUTICALS INC's ticker is LXRX and the CUSIP is 528872302. A total of 88 filers reported holding LEXICON PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $179,279 | -0.0% | 164,476 | +110.1% | 0.00% | – |
| Q2 2023 | $179,288 | +21.4% | 78,292 | +28.9% | 0.00% | – |
| Q1 2023 | $147,649 | +23.7% | 60,761 | -2.7% | 0.00% | – |
| Q4 2022 | $119,320 | -54.8% | 62,471 | -43.3% | 0.00% | – |
| Q3 2022 | $264,000 | +271.8% | 110,133 | +187.5% | 0.00% | – |
| Q2 2022 | $71,000 | -26.8% | 38,310 | -18.0% | 0.00% | – |
| Q1 2022 | $97,000 | -91.1% | 46,716 | -83.1% | 0.00% | – |
| Q4 2021 | $1,089,000 | +1096.7% | 276,523 | +1354.8% | 0.00% | – |
| Q3 2021 | $91,000 | -40.5% | 19,008 | -42.8% | 0.00% | – |
| Q2 2021 | $153,000 | -85.8% | 33,246 | -81.8% | 0.00% | – |
| Q1 2021 | $1,075,000 | +292.3% | 183,087 | +128.0% | 0.00% | – |
| Q4 2020 | $274,000 | +7.9% | 80,300 | -54.4% | 0.00% | – |
| Q3 2020 | $254,000 | +64.9% | 176,274 | +128.7% | 0.00% | – |
| Q2 2020 | $154,000 | +116.9% | 77,063 | +111.0% | 0.00% | – |
| Q1 2020 | $71,000 | -71.4% | 36,528 | -38.8% | 0.00% | – |
| Q4 2019 | $248,000 | -54.2% | 59,673 | -66.9% | 0.00% | – |
| Q3 2019 | $542,000 | -69.1% | 180,100 | -35.5% | 0.00% | – |
| Q2 2019 | $1,755,000 | -14.8% | 279,128 | -24.6% | 0.00% | – |
| Q1 2019 | $2,059,000 | +835.9% | 370,268 | +1021.3% | 0.00% | – |
| Q4 2018 | $220,000 | -62.1% | 33,020 | -39.5% | 0.00% | – |
| Q3 2018 | $581,000 | -44.9% | 54,538 | -37.9% | 0.00% | – |
| Q2 2018 | $1,054,000 | +47.6% | 87,788 | +5.4% | 0.00% | – |
| Q1 2018 | $714,000 | -58.1% | 83,317 | -51.8% | 0.00% | – |
| Q4 2017 | $1,706,000 | -77.6% | 172,695 | -72.2% | 0.00% | -100.0% |
| Q3 2017 | $7,632,000 | +120.5% | 620,925 | +195.1% | 0.00% | 0.0% |
| Q2 2017 | $3,461,000 | -38.3% | 210,380 | -46.2% | 0.00% | 0.0% |
| Q1 2017 | $5,607,000 | +61.0% | 391,019 | +55.2% | 0.00% | 0.0% |
| Q4 2016 | $3,483,000 | -1.8% | 251,876 | +28.4% | 0.00% | 0.0% |
| Q3 2016 | $3,546,000 | +24.4% | 196,172 | -1.3% | 0.00% | 0.0% |
| Q2 2016 | $2,851,000 | +22.7% | 198,690 | +2.2% | 0.00% | 0.0% |
| Q1 2016 | $2,323,000 | +168.6% | 194,341 | +198.8% | 0.00% | – |
| Q4 2015 | $865,000 | +35.4% | 65,042 | +9.3% | 0.00% | – |
| Q3 2015 | $639,000 | +301.9% | 59,505 | +200.5% | 0.00% | – |
| Q2 2015 | $159,000 | – | 19,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ulys, L.L.C. | 4,321,214 | $37,033,000 | 100.00% |
| Artal Group S.A. | 58,274,650 | $499,413,000 | 6.25% |
| SECTOR GAMMA AS | 854,592 | $7,324,000 | 1.32% |
| NEA Management Company, LLC | 2,382,286 | $20,416,000 | 0.91% |
| Virtus ETF Advisers LLC | 89,845 | $770,000 | 0.67% |
| Malaga Cove Capital, LLC | 59,701 | $512,000 | 0.28% |
| MARSHALL WACE, LLP | 736,545 | $6,312,000 | 0.26% |
| USS Investment Management Ltd | 2,741,942 | $22,607,000 | 0.25% |
| CLEARBRIDGE, LLC | 1,172,117 | $10,045,000 | 0.22% |
| WEDBUSH SECURITIES INC | 155,396 | $1,332,000 | 0.17% |